NDC codes

FDA NDC Directory
Product NDC (as listed)70518-4646Labeler and product segments. Claims need a package NDC.
Product NDC at billing width70518-4646Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
70518-4646-0705184646007051846460050 POUCH in 1 BOX (70518-4646-0) / 1 CAPSULE, EXTENDED RELEASE in 1 POUCH (70518-4646-1)Marketed from Apr 28, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Acetazolamide
Generic name (nonproprietary)
acetazolamide
Active ingredients
Acetazolamide — 500 mg/1
Dosage form
Capsule, Extended release
Route
Oral
Labeler
REMEDYREPACK INC.NDC labeler code 70518
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 040904
Marketing start
Listing expires
Other FDA classes
Carbonic Anhydrase Inhibitors (Mechanism)Sulfonamides (Chemical structure)
Identifiers
Product ID 70518-4646_508b15b8-2f21-c075-e063-6394a90af64dSPL ID 508b15b8-2f21-c075-e063-6394a90af64dSPL set ID fb2cf8fe-da81-445e-a18b-9aa9ced1d34aRxCUI 562524UNII O3FX965V0I
Pharmacologic class
Carbonic Anhydrase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N470518464600 followed by a unit qualifier and the quantity

Package 70518-4646-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE: For adjunctive treatment of: chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure. Acetazolamide extended-release capsules are also indicated for the prevention or amelioration of symptoms associated with acute mountain sickness despite gradual ascent.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 70518-4646

What is NDC 70518-4646?
70518-4646 is the product NDC for Acetazolamide, Acetazolamide 500 mg/1 capsule, extended release, listed with the FDA by REMEDYREPACK INC.. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Acetazolamide.
What is the active ingredient?
Acetazolamide.
Who is the labeler?
REMEDYREPACK INC., NDC labeler code 70518. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Acetazolamide?
71 other product NDCs are listed under this name. See all Acetazolamide NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Acetazolamide NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
Acetazolamideacetazolamide sodiumAcetazolamide sodium 500 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenousMylan Institutional LLC72078-09272078-0092-50
AcetazolamideAcetazolamide 125 mg/1TabletOralMarlex Pharmaceuticals, Inc.10135-83010135-0830-01
AcetazolamideAcetazolamide 250 mg/1TabletOralMarlex Pharmaceuticals, Inc.10135-83110135-0831-01
Acetazolamideacetazolamide sodiumAcetazolamide sodium 500 mg/5mLInjection, Powder, For solutionIntravenousSagent Pharmaceuticals25021-83925021-0839-20
AcetazolamideAcetazolamide sodium 500 mg/5mLInjection, Powder, Lyophilized, For solutionIntravenousGland Pharma Limited68083-66168083-0661-01
AcetazolamideAcetazolamide 125 mg/1TabletOralAurobindo Pharma Limited59651-90559651-0905-01
AcetazolamideAcetazolamide 250 mg/1TabletOralAurobindo Pharma Limited59651-90659651-0906-01
AcetazolamideAcetazolamide 250 mg/1TabletOralAarkish Pharmaceuticals NJ Inc.81005-10581005-0105-0181005-0105-10
AcetazolamideAcetazolamide 125 mg/1TabletOralAarkish Pharmaceuticals NJ Inc.81005-10481005-0104-0181005-0104-10
AcetazolamideAcetazolamide 125 mg/1TabletOralAjanta Pharma USA Inc.27241-13227241-0132-04

All 72 Acetazolamide NDCs

Other NDCs under ANDA 040904

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 040904
ProductStrengthForm · routeLabelerProduct NDC
AcetazolamideAcetazolamide 500 mg/1Capsule, Extended releaseOralHeritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.23155-787
AcetazolamideAcetazolamide 500 mg/1Capsule, Extended releaseOralA-S Medication Solutions50090-5945
AcetazolamideAcetazolamide 500 mg/1Capsule, Extended releaseOralChartwell RX, LLC62135-612

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in